We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$63.9B
AUM Growth
-$531M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,809
New
Increased
Reduced
Closed

Top Buys

1 +$800M
2 +$304M
3 +$261M
4
LIN icon
Linde
LIN
+$237M
5
JPM icon
JPMorgan Chase
JPM
+$208M

Top Sells

1 +$656M
2 +$632M
3 +$474M
4
PG icon
Procter & Gamble
PG
+$428M
5
MU icon
Micron Technology
MU
+$332M

Sector Composition

1 Technology 22.04%
2 Healthcare 15.35%
3 Industrials 11.12%
4 Consumer Discretionary 10.88%
5 Financials 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICFI icon
3651
ICF International
ICFI
$1.32B
-47,100
IDA icon
3652
Idacorp
IDA
$7.92B
-41,100
IDV icon
3653
iShares International Select Dividend ETF
IDV
$8.65B
-8,800
IEV icon
3654
iShares Europe ETF
IEV
$1.77B
-3,600
IGM icon
3655
iShares Expanded Tech Sector ETF
IGM
$10.6B
-14,000
IHI icon
3656
iShares US Medical Devices ETF
IHI
$3.03B
-29,100
IJR icon
3657
iShares Core S&P Small-Cap ETF
IJR
$107B
-17,500
ILF icon
3658
iShares Latin America 40 ETF
ILF
$4.35B
-134,700
IMMX icon
3659
Immix Biopharma
IMMX
$602M
-258,600
IMTM icon
3660
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.13B
-14,800
INDB icon
3661
Independent Bank
INDB
$4.02B
-18,002
INKT icon
3662
MiNK Therapeutics
INKT
$59.9M
-10,400
INOD icon
3663
Innodata
INOD
$3.29B
-25,854
INTR icon
3664
Inter&Co
INTR
$2.55B
-436,520
IOBT
3665
DELISTED
IO Biotech
IOBT
-207,601
IOVA icon
3666
Iovance Biotherapeutics
IOVA
$1.82B
-651,000
IQLT icon
3667
iShares MSCI Intl Quality Factor ETF
IQLT
$13.5B
-25,200
ISTB icon
3668
iShares Core 1-5 Year USD Bond ETF
ISTB
$4.91B
-41,800
ITB icon
3669
iShares US Home Construction ETF
ITB
$2.73B
-10,600
ITOT icon
3670
iShares Core S&P Total US Stock Market ETF
ITOT
$92.2B
-86,800
IUSG icon
3671
iShares Core S&P US Growth ETF
IUSG
$31.4B
-7,800
IVE icon
3672
iShares S&P 500 Value ETF
IVE
$48B
-31,700
IVDA icon
3673
Iveda Solutions
IVDA
$3.26M
-49,800
IVV icon
3674
iShares Core S&P 500 ETF
IVV
$838B
-34,420
IVW icon
3675
iShares S&P 500 Growth ETF
IVW
$73.2B
-12,900